FDC vs PGHL: Stock Comparison

FDC vs PROCTER & GAMBLE HEALTH LUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

PROCTER & GAMBLE HEALTH L is the larger company by market capitalisation. FDC shows a lower P/E, while PROCTER & GAMBLE HEALTH L shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

FDC leads 5; PGHL leads 7 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

FDCPGHL

Valuation lens

What price are you paying?

Market CapContext only
₹5,576 Cr
₹9,379 Cr
P/E RatioFDC has the lower reading
19.05x
26.43x
P/B RatioFDC has the lower reading
2.24x
17.98x
EPSPGHL has the higher reading
₹8.14
₹57.92
Book ValueContext only
₹152.64
₹316.01
Dividend YieldPGHL has the higher reading
1.46%
3.45%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
PGHL is the larger company
₹9,379 Cr vs ₹5,576 Cr
P/E Ratio
FDC has a lower P/E
19.05x vs 26.43x
P/B Ratio
FDC has a lower P/B
2.24x vs 17.98x
EPS
PGHL has higher earnings per share
₹57.92 vs ₹8.14
Dividend Yield
PGHL has a higher dividend yield
3.45% vs 1.46%
Revenue Growth (TTM YoY)
PGHL has faster revenue growth
19.1% vs 18.9%
EPS Growth (TTM YoY)
FDC has faster EPS growth
166.8% vs 54.6%
Qtr Sales Growth
FDC has stronger quarterly sales growth
1.92% vs -74.17%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFDCPGHL
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricFDCPGHL
Live Price₹342.8₹5,660
Day Change0.35%-1.69%
Volume1.2 L7,255
52-Week High₹527.8₹6,975
52-Week Low₹312.95₹4,707
Distance from 52W High-35.05%-18.85%

Valuation

MetricFDCPGHL
Market Cap₹5,576 Cr₹9,379 Cr
P/E Ratio19.05x26.43x
P/B Ratio2.24x17.98x
EPS₹8.14₹57.92
Book Value₹152.64₹316.01
Dividend Yield1.46%3.45%

Growth

MetricFDCPGHL
Revenue Growth (TTM YoY)18.9%19.1%
EPS Growth (TTM YoY)166.8%54.6%
Qtr Sales Growth1.92%-74.17%
Qtr Profit Growth0.36%-70.59%

Profitability & Leverage

MetricFDCPGHL
ROE11.47%62.32%
ROCE11.69%92.1%
Net Margin12.96%23.22%
Operating Margin18.03%31.99%
Debt to Equity0x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricFDCPGHL
Promoter Holding69.66%0%
FII Holding1.4% 1 pp6.33% 0.13 pp
DII Holding6.31% 0.02 pp12.44% 1.23 pp
Public Holding22.63% 0.98 pp29.42% 1.11 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FDC and PROCTER & GAMBLE HEALTH L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.